MIAMI LAKES, Fla., Sept. 30 /PRNewswire/ -- The U.S. District Court in
Delaware today entered final judgment including accrued interest, totaling
approximately $1.2 billion, to Cordis Corporation against Medtronic, Inc.
and Boston Scientific Corporation in cases involving the original Palmaz
balloon expandable stent patent. Juries in 2000 and 2005 found that Boston
Scientific's and Medtronic's bare metal stents infringed the Palmaz patent,
which is owned by Cordis Corporation. Medtronic was ordered to pay
approximately $521 million and Boston Scientific approximately $703
million.
The company is pleased that a judgment was entered and that the patent
for Dr. Palmaz's groundbreaking product has been acknowledged.
Cordis Corporation, a Johnson & Johnson company, is a worldwide leader
in the development and manufacture of interventional vascular technology.
Through the company's innovation, research and development, Cordis partners
with interventional cardiologists worldwide to treat millions of patients
who suffer from vascular disease. More information about Cordis Corporation
can be found at http://www.cordis.com.
SOURCE Cordis Corporation
 back to top
Related links:
http://www.cordis.com
CONTACT:
Media, Carol Goodrich, +1-908-412-7332, or
Investors, Louise Mehrotra, +1-732-524-6491, or Stan Panasewicz,
+1-732-524-2524
|
